Advertisement
Screener

CURIS, INC. (CRIS) Increase (Decrease) in Accounts Payable and Accrued Liabilities

2.8 / 5 stars · 68/120 Roast Me

CURIS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities

CURIS, INC. (CRIS) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$311.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-14

  • CURIS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$832.00K.
  • CURIS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $521.00K, a 79.66% increase year-over-year.
  • CURIS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $1.40M.
  • CURIS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $1.03M, a 62.96% decline year-over-year.
  • CURIS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $2.55M.
  • CURIS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was -$2.08M, a 162.19% decline from fiscal 2023.
  • CURIS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $3.34M.
  • CURIS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$3.88M, a 178.23% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filedIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filedIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filedIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 monthIncrease (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed
2026-06-30-$832.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$311.00K
10-Q · filed 2026-08-14
$1.09M
derived: sum of 3 quarters · filed 2026-08-14
$2.12M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$521.00K
10-Q · filed 2026-05-13
$1.92M
derived: sum of 2 quarters · filed 2026-05-13
$2.95M
derived: sum of 3 quarters · filed 2026-05-13
$2.78M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$1.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
$2.43M
derived: sum of 2 quarters · filed 2026-03-24
$2.26M
derived: sum of 3 quarters · filed 2026-08-14
$2.55M
10-K · filed 2026-03-24
2025-09-30$1.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$859.00K
derived: sum of 2 quarters · filed 2026-08-14
$1.15M
10-Q · filed 2025-11-06
-$635.00K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$171.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$119.00K
10-Q · filed 2026-08-14
-$1.67M
derived: sum of 3 quarters · filed 2026-08-14
$1.12M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$290.00K
10-Q · filed 2026-05-13
-$1.49M
derived: sum of 2 quarters · filed 2026-05-13
$1.29M
derived: sum of 3 quarters · filed 2026-05-13
$471.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$1.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
$997.00K
derived: sum of 2 quarters · filed 2026-03-24
$181.00K
derived: sum of 3 quarters · filed 2026-03-24
-$2.08M
10-K · filed 2026-03-24
2024-09-30$2.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$1.97M
derived: sum of 2 quarters · filed 2025-11-06
-$293.00K
10-Q · filed 2025-11-06
-$527.00K
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$816.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
-$3.07M
10-Q · filed 2025-08-05
-$3.31M
derived: sum of 3 quarters · filed 2025-08-05
$676.00K
derived: sum of 4 quarters · filed 2025-08-05
2024-03-31-$2.26M
10-Q · filed 2025-05-06
-$2.49M
derived: sum of 2 quarters · filed 2025-05-06
$1.49M
derived: sum of 3 quarters · filed 2025-05-06
$3.07M
derived: sum of 4 quarters · filed 2025-05-06
2023-12-31-$234.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$3.75M
derived: sum of 2 quarters · filed 2025-03-31
$5.32M
derived: sum of 3 quarters · filed 2025-03-31
$3.34M
10-K · filed 2025-03-31
2023-09-30$3.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
$5.56M
derived: sum of 2 quarters · filed 2024-11-14
$3.57M
10-Q · filed 2024-11-14
-$123.00K
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$1.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
-$410.00K
10-Q · filed 2024-08-01
-$4.11M
derived: sum of 3 quarters · filed 2024-08-01
-$2.62M
derived: sum of 4 quarters · filed 2024-08-01
2023-03-31-$1.98M
10-Q · filed 2024-05-07
-$5.68M
derived: sum of 2 quarters · filed 2024-05-07
-$4.20M
derived: sum of 3 quarters · filed 2024-05-07
-$1.98M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31-$3.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08
-$2.21M
derived: sum of 2 quarters · filed 2024-02-08
$6.00K
derived: sum of 3 quarters · filed 2024-02-08
-$3.88M
10-K · filed 2024-02-08
2022-09-30$1.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$3.70M
derived: sum of 2 quarters · filed 2023-11-02
-$187.00K
10-Q · filed 2023-11-02
$3.75M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30$2.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
-$1.67M
10-Q · filed 2023-08-03
$2.27M
derived: sum of 3 quarters · filed 2023-08-03
$3.85M
derived: sum of 4 quarters · filed 2023-08-03
2022-03-31-$3.89M
10-Q · filed 2023-05-04
$50.00K
derived: sum of 2 quarters · filed 2023-05-04
$1.63M
derived: sum of 3 quarters · filed 2023-05-04
$3.38M
derived: sum of 4 quarters · filed 2023-05-04
2021-12-31$3.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13
$5.52M
derived: sum of 2 quarters · filed 2023-03-13
$7.27M
derived: sum of 3 quarters · filed 2023-03-13
$4.96M
10-K · filed 2023-03-13
2021-09-30$1.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$3.33M
derived: sum of 2 quarters · filed 2022-11-09
$1.02M
10-Q · filed 2022-11-09
$1.34M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$1.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$557.00K
10-Q · filed 2022-08-04
-$241.00K
derived: sum of 3 quarters · filed 2022-08-04
$336.00K
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-$2.30M
10-Q · filed 2022-05-05
-$1.99M
derived: sum of 2 quarters · filed 2022-05-05
-$1.41M
derived: sum of 3 quarters · filed 2022-05-05
-$612.00K
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$316.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$893.00K
derived: sum of 2 quarters · filed 2022-02-24
$1.69M
derived: sum of 3 quarters · filed 2022-02-24
$1.00M
10-K · filed 2022-02-24
2020-09-30$577.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$1.37M
derived: sum of 2 quarters · filed 2021-11-09
$684.00K
10-Q · filed 2021-11-09
$2.75M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$796.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$107.00K
10-Q · filed 2021-08-03
$2.17M
derived: sum of 3 quarters · filed 2022-02-24
$2.75M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31-$689.00K
10-Q · filed 2021-05-12
$1.38M
derived: sum of 2 quarters · filed 2022-02-24
$1.95M
derived: sum of 3 quarters · filed 2022-02-24
$2.27M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$2.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$2.64M
derived: sum of 2 quarters · filed 2022-02-24
$2.96M
derived: sum of 3 quarters · filed 2022-02-24
$60.00K
10-K · filed 2022-02-24
2019-09-30$573.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
$889.00K
derived: sum of 2 quarters · filed 2020-11-10
-$2.01M
10-Q · filed 2020-11-10
-$1.97M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30$316.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
-$2.58M
10-Q · filed 2020-08-04
-$2.54M
derived: sum of 3 quarters · filed 2020-08-04
-$3.78M
derived: sum of 4 quarters · filed 2020-08-04
2019-03-31-$2.90M
10-Q · filed 2020-05-12
-$2.85M
derived: sum of 2 quarters · filed 2020-05-12
-$4.09M
derived: sum of 3 quarters · filed 2020-05-12
-$3.68M
derived: sum of 4 quarters · filed 2020-05-12
2018-12-31$40.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19
-$1.20M
derived: sum of 2 quarters · filed 2020-03-19
-$787.00K
derived: sum of 3 quarters · filed 2020-03-19
-$1.87M
10-K · filed 2020-03-19
2018-09-30-$1.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
-$827.00K
derived: sum of 2 quarters · filed 2019-11-05
-$1.91M
10-Q · filed 2019-11-05
-$2.37M
derived: sum of 4 quarters · filed 2019-11-05
2018-06-30$412.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$674.00K
10-Q · filed 2019-08-09
-$1.13M
derived: sum of 3 quarters · filed 2019-08-09
-$3.11M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31-$1.09M
10-Q · filed 2019-05-14
-$1.54M
derived: sum of 2 quarters · filed 2019-05-14
-$3.52M
derived: sum of 3 quarters · filed 2019-05-14
-$314.00K
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31-$454.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26
-$2.43M
derived: sum of 2 quarters · filed 2019-03-26
$772.00K
derived: sum of 3 quarters · filed 2019-03-26
-$376.00K
10-K · filed 2019-03-26
2017-09-30-$1.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$1.23M
derived: sum of 2 quarters · filed 2018-11-01
$78.00K
10-Q · filed 2018-11-01
$1.28M
derived: sum of 4 quarters · filed 2018-11-01
2017-06-30$3.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$2.06M
10-Q · filed 2018-08-02
$3.26M
derived: sum of 3 quarters · filed 2018-08-02
$4.72M
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31-$1.15M
10-Q · filed 2018-05-03
$58.00K
derived: sum of 2 quarters · filed 2018-05-03
$1.51M
derived: sum of 3 quarters · filed 2018-05-03
$1.12M
derived: sum of 4 quarters · filed 2018-05-03
2016-12-31$1.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$2.66M
derived: sum of 2 quarters · filed 2018-03-08
$2.27M
derived: sum of 3 quarters · filed 2018-03-08
$2.31M
10-K · filed 2018-03-08
2016-09-30$1.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$1.06M
derived: sum of 2 quarters · filed 2017-11-07
$1.11M
10-Q · filed 2017-11-07
$2.81M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30-$396.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
-$346.00K
10-Q · filed 2017-08-03
$1.35M
derived: sum of 3 quarters · filed 2018-03-08
$1.58M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$50.00K
10-Q · filed 2017-05-04
$49.92K
10-Q · filed 2016-05-09
$1.75M
derived: sum of 2 quarters · filed 2018-03-08
$1.98M
derived: sum of 3 quarters · filed 2018-03-08
$2.27M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$1.93M
derived: sum of 2 quarters · filed 2018-03-08
$2.22M
derived: sum of 3 quarters · filed 2018-03-08
$1.77M
10-K · filed 2018-03-08
$1.77M
10-K · filed 2016-02-29
2015-09-30$230.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$517.22K
derived: sum of 2 quarters · filed 2016-11-03
$76.00K
10-Q · filed 2016-11-03
$75.59K
10-Q · filed 2015-11-09
$91.53K
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$287.22K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
-$154.00K
10-Q · filed 2016-08-04
-$153.96K
10-Q · filed 2015-08-06
-$138.47K
derived: sum of 3 quarters · filed 2017-03-09
-$188.21K
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31-$441.22K
10-Q · filed 2016-05-09
-$425.70K
derived: sum of 2 quarters · filed 2017-03-09
-$475.43K
derived: sum of 3 quarters · filed 2017-03-09
$78.91K
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31$15.53K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
-$34.20K
derived: sum of 2 quarters · filed 2017-03-09
$520.13K
derived: sum of 3 quarters · filed 2017-03-09
$361.00K
10-K · filed 2017-03-09
$360.87K
10-K · filed 2015-02-24
2014-09-30-$49.73K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$504.60K
derived: sum of 2 quarters · filed 2015-11-09
$345.47K
10-Q · filed 2015-11-09
$90.85K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$554.34K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$395.20K
10-Q · filed 2015-08-06
$140.58K
derived: sum of 3 quarters · filed 2016-02-29
$443.22K
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$159.13K
10-Q · filed 2015-05-07
-$413.76K
derived: sum of 2 quarters · filed 2016-02-29
-$111.12K
derived: sum of 3 quarters · filed 2016-02-29
$465.60K
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$254.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$48.01K
derived: sum of 2 quarters · filed 2016-02-29
$624.73K
derived: sum of 3 quarters · filed 2016-02-29
$181.82K
10-K · filed 2016-02-29
2013-09-30$302.64K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$879.36K
derived: sum of 2 quarters · filed 2014-11-10
$436.45K
10-Q · filed 2014-11-10
$286.76K
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30$576.72K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
$133.81K
10-Q · filed 2014-08-07
-$15.88K
derived: sum of 3 quarters · filed 2015-02-24
$427.42K
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31-$442.91K
10-Q · filed 2014-05-09
-$592.60K
derived: sum of 2 quarters · filed 2015-02-24
-$149.30K
derived: sum of 3 quarters · filed 2015-02-24
-$417.07K
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31-$149.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
$293.61K
derived: sum of 2 quarters · filed 2015-02-24
$25.84K
derived: sum of 3 quarters · filed 2015-02-24
$20.32K
10-K · filed 2015-02-24
2012-09-30$443.30K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$175.53K
derived: sum of 2 quarters · filed 2013-11-12
$170.00K
10-Q · filed 2013-11-12
$491.06K
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30-$267.77K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
-$273.30K
10-Q · filed 2013-08-08
$47.76K
derived: sum of 3 quarters · filed 2014-03-13
$260.66K
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31-$5.52K
10-Q · filed 2013-05-09
$315.53K
derived: sum of 2 quarters · filed 2014-03-13
$528.43K
derived: sum of 3 quarters · filed 2014-03-13
$558.46K
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31$321.05K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$533.96K
derived: sum of 2 quarters · filed 2014-03-13
$563.99K
derived: sum of 3 quarters · filed 2014-03-13
$416.20K
10-K · filed 2014-03-13
2011-09-30$212.91K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
$242.94K
derived: sum of 2 quarters · filed 2012-11-06
$95.14K
10-Q · filed 2012-11-06
$1.13M
derived: sum of 4 quarters · filed 2013-03-13
2011-06-30$30.03K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
-$117.76K
10-Q · filed 2012-08-09
$914.26K
derived: sum of 3 quarters · filed 2013-03-13
$1.65M
derived: sum of 4 quarters · filed 2013-03-13
2011-03-31-$147.79K
10-Q · filed 2012-05-10
$884.23K
derived: sum of 2 quarters · filed 2013-03-13
$1.62M
derived: sum of 3 quarters · filed 2013-03-13
2010-12-31$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13
$1.77M
derived: sum of 2 quarters · filed 2013-03-13
$955.59K
10-K · filed 2013-03-13
2010-09-30$739.90K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31
-$76.44K
10-Q · filed 2011-10-31
2010-06-30-$816.33K
10-Q · filed 2011-08-04
2009-12-31-$186.12K
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Silexion Therapeutics Corp (SLXN)$0.001B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
VivoSim Labs, INC. (VIVS)United States$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70